The fastest growing AI solution in the US market

FDA-cleared Autonomous AI

The diabetic eye exam is now a
1-⁠minute step during the visit

AEYE-DS brings instant diabetic retinopathy diagnosis into the routine visit through portable, autonomous AI screening run by your existing staff. Referral delays and specialist bottlenecks disappear -and CPT 92229 is captured automatically.

Trusted integrations across the continuum of care

  • Epic
  • athenahealth
  • Cerner
  • eClinicalWorks

The Problem

The referral model is failing your patients and your practice

The traditional referral model fails over 60% of diabetic patients. This results in persistent care gaps, lower quality scores, and preventable vision loss.

  • 40M+ US adults with diabetes at risk
  • 95% Of blindness from DR is preventable
  • >60% Of patients miss their screening

The solution

The solution

AEYE-DS is the 1-⁠minute portable AI diabetic eye exam that actually happens

By replacing delayed teleretinal imaging and specialist bottlenecks with instant point-of-care AI, your team can close critical care gaps without disrupting their workflow, so no patient falls behind.

  1. Image Capture

    Per eye using a portable or tabletop camera rarely requiring dilation.
    99% image success rate.

  2. Autonomous AI Diagnosis

    On the spot, to be discussed in real time. Automated. EHR documentation.
    No manual entry.

  3. Care Gap Closed & Revenue Captured

    HEDIS EED compliance is documented.
    and CPT code 92229 billing is triggered.

Fully integrated with your EHR

Automates care gap alert, diagnosis documentation, and billing -adjusted to your workflow.

Clinical accuracy you can trust

AEYE-DS sets the highest clinical standard for autonomous diabetic retinopathy screening as the industry's only portable FDA-cleared solution.

92–93%
Sensitivity

Correctly identifies patients with diabetic retinopathy who need follow-⁠up care.

89–94%
Specificity

Correctly clears patients without DR, avoiding unnecessary referrals.

>99%
Imageability

Virtually every patient gets a usable image — even without dilation.

From referrals to real-time results

What changes when the diabetic retinopathy screening moves into the visit.

Before AEYE-DS
  • >60% of patients miss their annual exam due to referral friction
  • 40–60 min of staff coordination per patient in teleretinal workflows
  • Image failure rates up to 30% — retakes, delays, lost charts
  • Your clinic absorbs HEDIS and MIPS penalties
After AEYE-DS
  • Screening happens during the routine visit
    - no separate appointment
  • Results discussed on the spot, compliance automatically documented in real time in the EHR
  • >99% imageability — virtually every patient is screened
  • CPT 92229 billing is automatically triggered
  • Ophthalmology referrals triggered for patients who actually need them

Trusted by leading primary care teams across the US

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care

"AEYE-DS completely transformed how we handle diabetic screenings. Our compliance rates went from under 40% to nearly 90% in just a few months."

Dr. Sarah M. Medical Director, Primary Care
Get started

Turn every routine diabetic visit into a completed eye exam

Join the primary care teams across the US who are closing care gaps, capturing revenue, and protecting patient vision — all without adding a single extra appointment.

FDA-cleared · No obligation · Tailored to your EHR